What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Progenics Pharmaceuticals (PGNX) - Quote Info
stock in demand     25-Oct-09 11:52 am    
Progenics Pharmaceuticals have announced that they have entered an agreement with Wyeth Pharmaceuticals under which they will be regaining all the worldwide rights to the Relistor franchise from Wyeth Pharmaceuticals. Progenics had originally licensed the drug to Wyeth Pharmaceuticals four years ago but now they would like to take back the charge over the development of a subcutaneous version of the drug after the one year transition period.http://www.favstocks.com/progenics-wyeth...
Apart from the ongoing development of Relistor drug, Progenics Pharmaceuticals will also look after the future development and commercialization of Relistor drug.
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

tigerer@yma...


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
stock in demand
tigerer@yma... Not rated 25-Oct-09 11:52 am  
 
nice revisionist history congratulations all ar...
kreactor Rate it 2-Nov-09 10:55 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Progenics Pharmaceuticals Inc. (PGNX)

Chart for Progenics Pharmaceuticals Inc. (PGNX)
At 4:00PM ET: 4.44 Down 0.07 (1.55%)
Symbol Lookup